Alpha Teknova, Inc. Common Stock
$7.79
$0.34 (+4.56%)
$7.24Day Range$7.92
Key Statistics
Market Cap
$418.23M
Shares Outstanding
53.7M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 25, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$7.39
Day High
$7.92
Day Low
$7.24
Volume
502.4K
VWAP
$7.72
Prev Close
$7.45
Transactions
--
Acc. Volume
--
About Alpha Teknova, Inc. Common Stock
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESSIC 2835158 employees2451 BERT DRIVE, HOLLISTER, CA, 95023(831) 637-1100IPO Jun 25, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001850902
- Composite FIGI
- BBG00201BVN6
- Share Class FIGI
- BBG00201BVP4
- Ticker Root
- TKNO
- SIC Code
- 2835
About Alpha Teknova, Inc. Common Stock (TKNO) Stock
Alpha Teknova, Inc. Common Stock (TKNO) closed the 2026-09-18 session at $7.79, up 4.56% versus the previous close (+0.34). The stock opened at $7.39 and traded between $7.24 and $7.92 during that session. Session trading volume was 502K shares. The volume-weighted average price (VWAP) is $7.72.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
Alpha Teknova, Inc. Common Stock has a market capitalization of $418.2 million. The company operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES industry classification. TKNO is listed on the XNAS exchange. The company employs approximately 158 people. Alpha Teknova, Inc. Common Stock is headquartered in HOLLISTER, CA. The recorded listing date is 2021-06-25.
On this page you can find market TKNO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector.